NEXGEL, INC.

Profile

Company Names

NEXGEL, INC.
AQUAMED TECHNOLOGIES, INC.

Addresses

2150 CABOT BOULEVARD WEST, SUITE B, LANGHORNE, PA 19067

2150 CABOT BOULEVARD, WEST, SUITE B, LANGHORNE, PA 19067

850 THIRD AVENUE, SUITE 1801, NEW YORK, NY 10022

Phone Numbers

215-702-8550
(215) 702-8550
646-218-1405

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY, MANUFACTURING

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$4,620,690.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2021-09-02 
$1,620,000.00 
$2,500,000.00 
$880,000.00 
Debt 
5
2021-03-11 
$1,500,000.00 
$1,500,000.00 
$0.00 
Debt 
4
2020-11-25 
$515,000.00 
$515,000.00 
$0.00 
Equity 
3
2020-07-30 
$395,100.00 
$500,000.00 
$104,900.00 
Equity 
2
2019-09-10 
$175,000.00 
$750,000.00 
$575,000.00 
Equity 
1
2009-08-26 
$415,590.00 
$1,000,000.00 
$584,410.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
W 
CHORSKE 
DIRECTOR
AQUAMED TECHNOLOGIES, INC.
ADAM 
 
DRAPCZUK 
EXECUTIVE OFFICER
NEXGEL, INC.
STEVEN 
MARK 
GLASSMAN 
DIRECTOR
NEXGEL, INC.
N/A 
 
HARBORVIEW MASTER FUND, L.P. 
PROMOTER
AQUAMED TECHNOLOGIES, INC.
ADAM 
 
LEVY 
EXECUTIVE OFFICER, DIRECTOR
NEXGEL, INC.   |  CRATE INC.   |  MINERALYS THERAPEUTICS, INC.   |  TIGER + BULLDOG OHIO FUND, LP
ADAM 
R. 
LEVY 
EXECUTIVE OFFICER
AQUAMED TECHNOLOGIES, INC.
BENJAMIN 
 
MAYER 
EXECUTIVE OFFICER, DIRECTOR
AQUAMED TECHNOLOGIES, INC.   |  ENDEAVOR SCHOOLS, LLC
RICHARD 
 
ROSENBLUM 
EXECUTIVE OFFICER, DIRECTOR
AQUAMED TECHNOLOGIES, INC.   |  HEPALIFE TECHNOLOGIES INC   |  CELSIA TECHNOLOGIES, INC.   |  HARBORVIEW VALUE FUND LP   |  ALLIQUA, INC.   |  CHATAND INC   |  RESIDENCE AT OVERBROOK, L.P.   |  47 WALNUT TR LLC   |  AMBER KINETICS, INC.   |  VICAPSYS LIFE SCIENCES, INC.
YAAKOV 
 
SPINRAD 
DIRECTOR
NEXGEL, INC.   |  THIRD EYE HEALTH, INC.
DAVID 
 
STEFANSKY 
DIRECTOR
HEPALIFE TECHNOLOGIES INC   |  HARBORVIEW VALUE FUND LP   |  ALLIQUA, INC.   |  KALYTERA THERAPEUTICS, INC.   |  EHAVE, INC.   |  AQUAMED TECHNOLOGIES, INC.   |  NEXGEL, INC.
NACHUM 
 
STEIN 
DIRECTOR
AQUAMED TECHNOLOGIES, INC.   |  NEXGEL, INC.   |  AMERICAN EUROPEAN GROUP, INC.
MIRANDA 
J 
TOLEDANO 
DIRECTOR
NEXGEL, INC.
JOE 
 
WILLIAMS 
EXECUTIVE OFFICER
AQUAMED TECHNOLOGIES, INC.   |  APRICITY ROBOTICS INC.
JEROME 
 
ZELDIS 
DIRECTOR
ALLIQUA, INC.   |  BIOSIG TECHNOLOGIES, INC.   |  KALYTERA THERAPEUTICS, INC.   |  ALLIQUA BIOMEDICAL, INC.   |  AIT THERAPEUTICS, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.   |  NEXGEL, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-09-17
D
Link
OTHER HEALTH CARE 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Debt 
2021-09-02 
2021-03-23
D
Link
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Debt 
2021-03-11 
2021-03-23
D
Link
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2020-11-25 
2020-08-21
D
Link
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2020-07-30 
2019-09-25
D
Link
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2019-09-10 
2009-08-28
D
Link
MANUFACTURING 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ALERE FINANCIAL PARTNERS, A DIVISION OF COVA CAPITAL PARTNERS, LLC
109761
NONE
NONE
ALERE FINANCIAL PARTNERS, A DIVISION OF COVA CAPITAL PARTNERS, LLC
109761